^
Association details:
Biomarker:No biomarker
Cancer:Esophageal Cancer
Regimen:CaT (carboplatin + paclitaxel)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Esophageal and Esophagogastric Junction Cancers: Other Recommended Regimens…Paclitaxel with cisplatin or carboplatin.